Nrgene Technologies Ltd (NRGN) — Capital Reinvestment Ratio
Latest as of December 2025:
0.45x
Nrgene Technologies Ltd (NRGN) has a Capital Reinvestment Ratio of 0.45x as of December 2025, meaning it reinvests 0% of its operating cash flow (ILA1.73 Million) in capital expenditures (ILA775.50K). See Nrgene Technologies Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.45x
Capex / Operating Cash Flow
Operating Cash Flow
ILA1.73 Million
ILA
Capital Expenditures
ILA775.50K
ILA
Data as of
Dec 2025
Most recent filing
Nrgene Technologies Ltd Capital Reinvestment Ratio (2025–2025)
This chart tracks Nrgene Technologies Ltd's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Nrgene Technologies Ltd (2025–2025)
Year-by-year Capital Reinvestment Ratio for Nrgene Technologies Ltd from 2025 to 2025. For live market cap and broader valuation context, see NRGN stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (ILA) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.92x | ILA855.00K | ILA783.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow